What Defines a Value Stock?
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
The following stocks are considered to be notable value stocks in the healthcare sector:
- AMN Healthcare Services (NYSE:AMN) – P/E: 8.27
- Zymeworks (NASDAQ:ZYME) – P/E: 4.94
- Cullinan Oncology (NASDAQ:CGEM) – P/E: 4.22
- ProPhase Labs (NASDAQ:PRPH) – P/E: 8.22
- QuidelOrtho (NASDAQ:QDEL) – P/E: 9.42
This quarter, AMN Healthcare Services experienced a decrease in earnings per share, which was $2.57 in Q3 and is now $2.48. Zymeworks has reported Q4 earnings per share at $4.71, which has increased by 813.64% compared to Q3, which was -0.66. Cullinan Oncology saw a decrease in earnings per share from -0.54 in Q3 to $-0.59 now. ProPhase Labs saw a decrease in earnings per share from 0.06 in Q3 to $-0.08 now. QuidelOrtho saw a decrease in earnings per share from 1.85 in Q3 to $1.76 now.
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.
